Alzheimer's disease (AD) is the cause of more than two-thirds of all dementia cases. Although there is no effective treatment against this disorder, its association with neuroinflammation suggests that non-steroidal anti-inflammatory drugs (NSAIDs) might represent a potential therapeutic option. The objective of this study was to evaluate the efficacy of NSAIDs in the treatment of AD using a meta-analysis approach.2.610 JCR (2015) Q2, 22/49 Geriatrics & gerontology, 98/253 Pharmacology & pharmacyUE
BACKGROUND: Previous studies have suggested that the use of nonsteroidal antiinflammatory drugs (NSA...
Alzheimer’s disease (AD) is characterized by cerebral deposits of b-amyloid (Ab) peptides and neurof...
Epidemiological evidence suggests non-steroidal anti-inflammatory drugs reduce the risk of Alzheimer...
The role of nonsteroidal anti-inflammatory drugs (NSAIDs) in prevention of Alzheimer’s disease (AD) ...
Item does not contain fulltextEver since inflammatory mediators were detected in and around amyloid ...
There is significant epidemiological evidence to suggest that there are beneficial effects of treatm...
<p><b>Introduction</b>: There is an increasing recognition of the immune system as an important medi...
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease (AD) is controversi...
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer’s disease (AD) is controversi...
Several epidemiological studies suggest that long-term use of non-steroidal anti-inflammatory drugs ...
We reviewed the records of 210 patients in the Johns Hopkins Alzheimer's Disease Research Center to ...
BACKGROUND Alzheimer's disease (AD) is the most common form of dementia. The incidence of AD rise...
OBJECTIVE: Recently, greater attention has been paid to the role of inflammatory processes in the p...
Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative diseases...
Alzheimer's disease (AD) is the most common form of neurodegenerative dementias worldwide. Amyl...
BACKGROUND: Previous studies have suggested that the use of nonsteroidal antiinflammatory drugs (NSA...
Alzheimer’s disease (AD) is characterized by cerebral deposits of b-amyloid (Ab) peptides and neurof...
Epidemiological evidence suggests non-steroidal anti-inflammatory drugs reduce the risk of Alzheimer...
The role of nonsteroidal anti-inflammatory drugs (NSAIDs) in prevention of Alzheimer’s disease (AD) ...
Item does not contain fulltextEver since inflammatory mediators were detected in and around amyloid ...
There is significant epidemiological evidence to suggest that there are beneficial effects of treatm...
<p><b>Introduction</b>: There is an increasing recognition of the immune system as an important medi...
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease (AD) is controversi...
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer’s disease (AD) is controversi...
Several epidemiological studies suggest that long-term use of non-steroidal anti-inflammatory drugs ...
We reviewed the records of 210 patients in the Johns Hopkins Alzheimer's Disease Research Center to ...
BACKGROUND Alzheimer's disease (AD) is the most common form of dementia. The incidence of AD rise...
OBJECTIVE: Recently, greater attention has been paid to the role of inflammatory processes in the p...
Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative diseases...
Alzheimer's disease (AD) is the most common form of neurodegenerative dementias worldwide. Amyl...
BACKGROUND: Previous studies have suggested that the use of nonsteroidal antiinflammatory drugs (NSA...
Alzheimer’s disease (AD) is characterized by cerebral deposits of b-amyloid (Ab) peptides and neurof...
Epidemiological evidence suggests non-steroidal anti-inflammatory drugs reduce the risk of Alzheimer...